Literature DB >> 4165690

An acquired inhibitor to coagulation factor 13.

J H Lewis, I L Szeto, L D Ellis, W L Bayer.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 4165690

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


× No keyword cloud information.
  6 in total

1.  A pathological inhibitor of fibrin cross-linking.

Authors:  L Lorand; A Jacobsen; J Bruner-Lorand
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

Review 2.  Acquired FXIII inhibitors: a systematic review.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 3.  The fibrin stabilizing factor, factor XIII.

Authors:  F Duckert
Journal:  Blut       Date:  1973-03

Review 4.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

5.  Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.

Authors:  G R Milner; P J Holt; J Bottomley; J E Maciver
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

6.  Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.

Authors:  L Lorand; T Urayama; J W De Kiewiet; H L Nossel
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.